Komori
Management planning4409TOHO CHEMICAL INDUSTRY COMPANY,LIMITEDMaterials and Chemicals

Notice Regarding the Formulation of the Medium-Term Management Plan “TOHO Step Up Plan 2027” and Initiatives to Achieve Management Conscious of Cost of Capital and Share Price

The company newly formulated the three-year medium-term management plan “TOHO Step Up Plan 2027,” covering fiscal 2025 through fiscal 2027. For the final year, it aims to achieve revenue of ¥60 billion, operating income of ¥3 billion, ROE of 8% and a dividend of ¥30 per share. The plan also incorporates measures to improve performance with awareness of cost of capital and PBR.

Worth reading
78Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
30
億円(2028年3月期連結営業利益目標)
Wording
Conditional
How definitive the wording is.

Items stated in the management plan

Formulated
TOHO Step Up Plan 2027Plan period 2025年度~2027年度(2025年4月~2028年3月)
Date of board resolution 14 May 2025 · Publication date 14 May 2025
Net Sales+11.9%
基準 536Target600Hundreds of millions of yen
Operating profit+65.7%
基準 18.1Target30Hundreds of millions of yen
Operating profit margin+1.6pt
基準 3.4Target5%
ROE+0.3pt
基準 7.7Target8%

Each line is the climb from the baseline the document states to the target it sets. The slope is scaled against the largest climb in this document. For metrics expressed as percentages, differences are shown in percentage points (pt).The increase shown by the dotted line is calculated from the two reported figures because the company did not provide the amount of growth.

What happened to the previous planNet Sales ¥60 billion / Operating profit ¥3 billion / Operating Margin 5.0% / Net assets ¥20.5 billion / Equity ratio 28.0% / ROE At least 10% / Dividend per share ¥20 → Net Sales ¥53.6 billion / Operating profit 18.1億円 / Operating Margin 3.4% / Net assets ¥21.0 billion / Equity ratio 30.9% / ROE 7.7% / Dividend per share ¥20(Net Sales ▲10.7% / Operating profit ▲39.7% / Operating Margin ▲32.0% / Net assets 約2.4%増 / Equity ratio 約10.4%増 / ROE ▲約23.0% / Dividend per share 0%)
Total investment plan2026年3月期~2028年3月期の3期間合計で設備投資120億円
Investment amount by sectorField Expansion of a plant for electronic information materials / Amount ¥2.3 billion, Field Expansion of pressure reaction facilities at 東邦化学(上海)有限公司 / Amount ¥2.2 billion
Statements about the use of capital
Payout ratio / DOE policy配当性向・DOEの数値目標はNot disclosed。内部留保とのバランスを考えながら配当を充実させ、本中計最終年度(2027年度)に1株当たり配当額30円、2030年度に50円を目指す。The payout ratio is the proportion of profit paid out as dividends, while DOE is the ratio of dividends to net assets.
Treasury share acquisition policy2026年3月期~2028年3月期の3期間において、配当に加え、機動的な自己株式取得も検討する。取得額・時期・条件はNot disclosed。
Cost of capitalCost of equity: 5–7% (five-year average: 6%)The cost of capital is the minimum rate of return expected by shareholders and banks from the company.
Self-assessment of PBR and share price2025年3月期のPBRは0.71倍、PERは9.2倍。利益率、総資産回転率、株主還元、IR活動などに改善余地があり、PBRの早期改善を図ると認識している。PBR is a measure of how many times the share price is the book value per share.
Key initiatives
01電子情報材料事業の拡大・中核事業化
02東邦化学(上海)有限公司を成長軌道に乗せ、海外市場開拓の取り組みを強化
03高機能・高付加価値製品の開発を加速
04最適生産体制構築による生産性改善及び業務効率化
05資本効率・財務体質・PBRの改善
06人的資本強化の取り組み推進
07脱炭素化へ向けたサステナビリティ活動の取り組み強化
Plan assumptions汎用石油化学製品を中心に、新興国企業による安価品での攻勢の影響が拡大, AI・DXに関する技術革新のスピード加速により、半導体関連需要は中長期的に伸長する見通し, 採用難による慢性的な人材不足、人件費の高騰, 物価の高騰や金利の上昇, 為替レート、原材料価格、市場成長率などの定量的前提はNot disclosed
Segment targetSegment Surfactants / Fiscal year ended March 2025: actual 7.3億円 / Plan for the fiscal year ending March 2028 12~13億円 / Indicator Operating profit, Segment Resins / Fiscal year ended March 2025: actual 0.9億円 / Plan for the fiscal year ending March 2028 2~3億円 / Indicator Operating profit, Segment Chemical Products / Fiscal year ended March 2025: actual ¥70 million / Plan for the fiscal year ending March 2028 1~2億円 / Indicator Operating profit, Segment Specialty chemicals / Fiscal year ended March 2025: actual 9.5億円 / Plan for the fiscal year ending March 2028 15~16億円 / Indicator Operating profit, Segment その他+調整額 / Fiscal year ended March 2025: actual -¥0.04 billion / Plan for the fiscal year ending March 2028 Not disclosed / Indicator Operating profit
Non-financial targetsIndicator 出産・育児・介護を理由とした離職率 / Target 0% / Timing Not disclosed, Indicator 有休休暇義務日数(5日)消化率 / Target 100% / Timing Not disclosed, Indicator 障がい者法定雇用率達成率 / Target At least 100% / Timing Not disclosed, Indicator 国内GHG排出量(Scope1+2)の売上高原単位 / Target 2013年度対比35%削減 / Timing By 2030
Size of the Target Market市場規模・市場成長率の数値および出典はNot disclosed
Risks identified by the company
新興国企業による安価品攻勢とグローバル競争の激化
日本国内の石化事業再編
米中経済対立と米国関税の影響
EV化の進展等による日本・自動車産業の地盤沈下
半導体関連ケミカル製品の競争激化
少子高齢化、採用難による人材不足、人件費の高騰
インフレ、物価高騰、金利上昇
一般的な業界・市場の状況、金利、通貨為替変動などの国内外の経済状況
Items stated in the management plan
ItemDetails
Plan nameTOHO Step Up Plan 2027
Plan period2025年度~2027年度(2025年4月~2028年3月)
Progress against the planFormulated
Sales Target2025年3月期実績 536億円 → 2028年3月期計画 600億円(約11.9%増)
Operating profit target2025年3月期実績 18.1億円 → 2028年3月期計画 30億円(約65.7%増)
Operating profit margin target2025年3月期実績 3.4% → 2028年3月期計画 5.0%(約47.1%増)
ROE target2025年3月期実績 7.7% → 本中計期間 8%以上(約3.9%以上)
Payout ratio / DOE policy配当性向・DOEの数値目標はNot disclosed。内部留保とのバランスを考えながら配当を充実させ、本中計最終年度(2027年度)に1株当たり配当額30円、2030年度に50円を目指す。
Treasury share acquisition policy2026年3月期~2028年3月期の3期間において、配当に加え、機動的な自己株式取得も検討する。取得額・時期・条件はNot disclosed。
Cost of capitalCost of equity: 5–7% (five-year average: 6%)
Self-assessment of PBR and share price2025年3月期のPBRは0.71倍、PERは9.2倍。利益率、総資産回転率、株主還元、IR活動などに改善余地があり、PBRの早期改善を図ると認識している。
Total investment plan2026年3月期~2028年3月期の3期間合計で設備投資120億円
Investment amount by sectorField Expansion of a plant for electronic information materials / Amount ¥2.3 billion, Field Expansion of pressure reaction facilities at 東邦化学(上海)有限公司 / Amount ¥2.2 billion
Segment targetSegment Surfactants / Fiscal year ended March 2025: actual 7.3億円 / Plan for the fiscal year ending March 2028 12~13億円 / Indicator Operating profit, Segment Resins / Fiscal year ended March 2025: actual 0.9億円 / Plan for the fiscal year ending March 2028 2~3億円 / Indicator Operating profit, Segment Chemical Products / Fiscal year ended March 2025: actual ¥70 million / Plan for the fiscal year ending March 2028 1~2億円 / Indicator Operating profit, Segment Specialty chemicals / Fiscal year ended March 2025: actual 9.5億円 / Plan for the fiscal year ending March 2028 15~16億円 / Indicator Operating profit, Segment その他+調整額 / Fiscal year ended March 2025: actual -¥0.04 billion / Plan for the fiscal year ending March 2028 Not disclosed / Indicator Operating profit
Non-financial targetsIndicator 出産・育児・介護を理由とした離職率 / Target 0% / Timing Not disclosed, Indicator 有休休暇義務日数(5日)消化率 / Target 100% / Timing Not disclosed, Indicator 障がい者法定雇用率達成率 / Target At least 100% / Timing Not disclosed, Indicator 国内GHG排出量(Scope1+2)の売上高原単位 / Target 2013年度対比35%削減 / Timing By 2030
Plan assumptions汎用石油化学製品を中心に、新興国企業による安価品での攻勢の影響が拡大, AI・DXに関する技術革新のスピード加速により、半導体関連需要は中長期的に伸長する見通し, 採用難による慢性的な人材不足、人件費の高騰, 物価の高騰や金利の上昇, 為替レート、原材料価格、市場成長率などの定量的前提はNot disclosed
Key initiatives電子情報材料事業の拡大・中核事業化, 東邦化学(上海)有限公司を成長軌道に乗せ、海外市場開拓の取り組みを強化, 高機能・高付加価値製品の開発を加速, 最適生産体制構築による生産性改善及び業務効率化, 資本効率・財務体質・PBRの改善, 人的資本強化の取り組み推進, 脱炭素化へ向けたサステナビリティ活動の取り組み強化
Results under the previous planNet Sales ¥60 billion / Operating profit ¥3 billion / Operating Margin 5.0% / Net assets ¥20.5 billion / Equity ratio 28.0% / ROE At least 10% / Dividend per share ¥20 → Net Sales ¥53.6 billion / Operating profit 18.1億円 / Operating Margin 3.4% / Net assets ¥21.0 billion / Equity ratio 30.9% / ROE 7.7% / Dividend per share ¥20(Net Sales ▲10.7% / Operating profit ▲39.7% / Operating Margin ▲32.0% / Net assets 約2.4%増 / Equity ratio 約10.4%増 / ROE ▲約23.0% / Dividend per share 0%)
Size of the Target Market市場規模・市場成長率の数値および出典はNot disclosed
Risks identified新興国企業による安価品攻勢とグローバル競争の激化, 日本国内の石化事業再編, 米中経済対立と米国関税の影響, EV化の進展等による日本・自動車産業の地盤沈下, 半導体関連ケミカル製品の競争激化, 少子高齢化、採用難による人材不足、人件費の高騰, インフレ、物価高騰、金利上昇, 一般的な業界・市場の状況、金利、通貨為替変動などの国内外の経済状況
Date of board resolution14 May 2025
Publication date14 May 2025
Items this document does not state (3)
Net income targetROIC targetReason for revision or withdrawal

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

改定した経営理念等、当社グループの各種方針や重要課題(マテリアリティ)を加味して新中計を策定し、次の3年間を「持続可能な成長と価値創造のための変革期」と位置づけた。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Formulation of the Medium-Term Management Plan “TOHO Step Up Plan 2027” and Initiatives to Achieve Management Conscious of Cost of Capital and Share Price | TOHO CHEMICAL INDUSTRY COMPANY,LIMITED (4409) timely disclosure | Komori